Find uplifting stories about heroes, innovations, and solutions
286 results for "hiv"
Scientists discovered that when HIV develops resistance to the groundbreaking drug lenacapavir, the virus loses its ability to spread effectively. This finding offers hope that the twice-yearly injection can remain a powerful tool in preventing and treating HIV.
Nigeria just launched a bold five-year plan to fund its own HIV programs instead of relying on international donors. The shift comes as the country has cut new infections by half since 2010 while treating nearly 2 million people living with HIV.
Three people have successfully suppressed HIV for months without their regular medication, bringing researchers closer to what they're calling a "functional cure" for the virus. This breakthrough represents a major step forward in decades of HIV research.
Tovhowani Makondo was diagnosed with HIV at 20 after fleeing rejection in her rural South African community. Today, she's back in school, working, and showing young LGBTQI people that an HIV diagnosis is not the end.
Researchers at Case Western Reserve University are using cancer treatment techniques to wake up the immune system and hunt down HIV hiding in the body. The breakthrough could one day help people living with HIV reduce or stop lifelong medication.
A 63-year-old man became the first person to achieve HIV remission through a bone marrow transplant from his sibling, opening new possibilities for HIV treatment. His brother carried a rare genetic mutation that makes cells resistant to the virus.
Liberia's National AIDS Commission is touring counties to strengthen HIV response coordination, marking a shift toward local ownership as donor funding declines. Nimba County just pledged $5,000 to support community-level HIV programs.
South Africa is partnering with Gilead Sciences to manufacture a revolutionary HIV prevention medicine that requires just two injections per year. The deal could bring affordable access to a drug that offers near-complete protection against HIV infection.
A rare group of people can naturally suppress HIV without medication, and their immune systems may hold the key to curing 40 million people worldwide. Researchers studying these "elite controllers" believe they're closer than ever to understanding how the human body can beat HIV on its own.
Mozambique just became one of the first African nations to offer lenacapavir, a groundbreaking HIV prevention injection that's 99% effective and only needs two doses per year. The new option could be life-changing for the 92,000 people who contracted HIV in the country last year.
Scientists discovered that common flu antivirals like Tamiflu might help reverse the inflammation causing cognitive problems in people living with HIV. The breakthrough could improve quality of life for millions as the HIV population ages.
A twice-yearly injectable that's nearly 100% effective at preventing HIV is transforming lives in Eswatini, the first African nation to offer this breakthrough treatment. In just four months, over 2,750 people have received the drug that could prevent one in three new HIV infections across Eastern and Southern Africa.
Breakthrough weight loss medications like Ozempic could help address rising obesity rates among people living with HIV in South Africa. Early research suggests these drugs work just as well for HIV patients as everyone else.
Nigeria just launched a bold new plan to fund its own HIV programs instead of relying on international donors. The five-year strategy aims to integrate HIV care into the country's regular health systems by 2030.
Starting HIV treatment immediately after diagnosis can prevent irreversible brain damage, giving 1.75 million older South Africans living with the virus hope for healthier cognitive futures. New research shows that while HIV can reach the brain within two weeks of infection, prompt treatment stops damage before it starts.
A simpler two-drug HIV treatment performed just as well as the current gold standard in clinical trials, with FDA approval expected this April. The breakthrough could offer people living with HIV a new option with fewer side effects.
A groundbreaking new HIV treatment offers people living with the virus a simpler, once-daily option that works differently from existing medications. The FDA just approved Idvynso, expanding choices for the 1.2 million Americans managing HIV.
Scientists at McGill University discovered that lithium, a common bipolar disorder medication, can keep dormant HIV from reactivating in cells. The breakthrough offers fresh hope for a functional cure that could one day reduce the need for daily HIV medication.
Patient advocates from 30 countries are already calling on Merck to ensure its promising monthly HIV prevention pill reaches everyone who needs it. The treatment could revolutionize HIV prevention by replacing daily pills with a once-a-month option.
Nigeria will introduce a twice-yearly HIV prevention injection in March 2026 that's 99.9% effective and costs just $40 per year. The breakthrough drug could transform HIV prevention for 1.9 million Nigerians living with the virus.
Showing 20 of 286